litlas
ログインアカウント作成

Dawn L. Hershman

1994–2026 年に発表

245
論文数
30,812
被引用数
101
h 指数
228
i10 指数

被引用数

Dawn L. Hershman の年別被引用数1992 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 3 件1999 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 5 件2003 年: 被引用 6 件2004 年: 被引用 7 件2005 年: 被引用 15 件2006 年: 被引用 28 件2007 年: 被引用 51 件2008 年: 被引用 68 件2009 年: 被引用 90 件2010 年: 被引用 110 件2011 年: 被引用 110 件2012 年: 被引用 144 件2013 年: 被引用 186 件2014 年: 被引用 215 件2015 年: 被引用 248 件2016 年: 被引用 222 件2017 年: 被引用 262 件2018 年: 被引用 210 件2019 年: 被引用 902 件2020 年: 被引用 980 件2021 年: 被引用 1,078 件2022 年: 被引用 950 件2023 年: 被引用 684 件2024 年: 被引用 1,303 件2025 年: 被引用 563 件2026 年: 被引用 13 件1993〜1994 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,753 件、この内訳の 34.3%中国: 引用元論文 835 件、この内訳の 7.6%イギリス: 引用元論文 643 件、この内訳の 5.9%カナダ: 引用元論文 558 件、この内訳の 5.1%イタリア: 引用元論文 542 件、この内訳の 4.9%ドイツ: 引用元論文 389 件、この内訳の 3.6%オーストラリア: 引用元論文 343 件、この内訳の 3.1%フランス: 引用元論文 326 件、この内訳の 3%スペイン: 引用元論文 253 件、この内訳の 2.3%オランダ: 引用元論文 245 件、この内訳の 2.2%日本: 引用元論文 226 件、この内訳の 2.1%スイス: 引用元論文 176 件、この内訳の 1.6%
0%34.3%その他 24.3%

機関

分野

  • Medicine75.5%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Economics, Econometrics and Finance2.6%
  • Health Professions1.2%
  • Immunology and Microbiology0.9%
  • Psychology0.7%
  • その他4.3%

トピック

  • Cancer survivorship and care4.2%
  • Cancer Treatment and Pharmacology4%
  • Breast Cancer Treatment Studies3.2%
  • Global Cancer Incidence and Screening2.4%
  • Cancer Risks and Factors2.3%
  • Endometrial and Cervical Cancer Treatments2.2%
  • その他81.7%

共著者

全論文

検索で開く
  1. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

    著者: Larissa A. Korde, Mark R. Somerfield, Lisa A. Carey, Jennie R. Crews, Neelima Denduluri, E. Shelley Hwang, Seema A. Khan, Sibylle Loibl, Elizabeth A. Morris, Alejandra Perez, Meredith M. Regan, Patricia A. Spears, Preeti Sudheendra, W. Fraser Symmans, Rachel L. Yung, Brittany Harvey, Dawn L. Hershman - Journal of Clinical Oncology 2021 被引用: 998

  2. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

    著者: Charles L. Loprinzi, Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Daniel L. Hertz, Mark R. Kelley, Antoinette Lavino, Maryam B. Lustberg, Judith A. Paice, Bryan P. Schneider, Elizabeth Smith, Mary Lou Smith, Thomas J. Smith, Nina D. Wagner‐Johnston, Dawn L. Hershman - Journal of Clinical Oncology 2020 被引用: 1,057

  3. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

    著者: Joseph M. Unger, Riha Vaidya, Dawn L. Hershman, Lori M. Minasian, Mark E. Fleury - JNCI Journal of the National Cancer Institute 2018 被引用: 560

  4. Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

    著者: Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Judith M. Bliss, Priya Rastogi, Manuela Rabaglio, Som D. Mukherjee, John R. Mackey, Vandana G. Abramson, Conrad D. Oja, Robert Wesolowski, Alastair M. Thompson, Daniel Rea, Paul M. Stos, Lois E. Shepherd, Vuk Stambolic, Wendy R. Parulekar - JAMA 2022 被引用: 223

  5. Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial

    著者: Kevin Kalinsky, Melissa Accordino, Codruța Chiuzan, Prabhjot S. Mundi, Elizabeth Sakach, Claire Sathe, Heejoon Ahn, Meghna S. Trivedi, Yelena Novik, Amy Tiersten, George Raptis, Lea Baer, Sun Young Oh, Amelia Zelnak, Kari B. Wisinski, Eleni Andreopoulou, William J. Gradishar, Erica Stringer-Reasor, Sonya Reid, Anne O’Dea, Ruth O’Regan, Katherine D. Crew, Dawn L. Hershman - Journal of Clinical Oncology 2023 被引用: 191

  6. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

    著者: Joseph M. Unger, Riha Vaidya, Kathy S. Albain, Michael LeBlanc, Lori M. Minasian, Carolyn C. Gotay, N. Lynn Henry, Michael J. Fisch, Shing M. Lee, Charles D. Blanke, Dawn L. Hershman - Journal of Clinical Oncology 2022 被引用: 317

  7. “When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

    著者: Joseph M. Unger, Dawn L. Hershman, Cathee Till, Lori M. Minasian, Raymond U. Osarogiagbon, Mark E. Fleury, Riha Vaidya - JNCI Journal of the National Cancer Institute 2020 被引用: 248

  8. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline

    著者: Judith A. Paice, Kari Bohlke, Debra L. Barton, David S. Craig, Areej El‐Jawahri, Dawn L. Hershman, Lynn R Kong, Geana Paula Kurita, Thomas W. LeBlanc, Sebastiano Mercadante, Kristina L. M. Novick, Ramy Sedhom, Carole Seigel, Joanna Stimmel, Éduardo Bruera - Journal of Clinical Oncology 2022 被引用: 259

  9. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline

    著者: Gary H. Lyman, Heather Greenlee, Kari Bohlke, Ting Bao, Angela DeMichele, Gary Deng, Judith M. Fouladbakhsh, Brigitte Gil, Dawn L. Hershman, Sami Mansfield, Dawn M. Mussallem, Karen M. Mustian, Erin Price, Susan Rafte, Lorenzo Cohen - Journal of Clinical Oncology 2018 被引用: 415

  10. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

    著者: Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn L. Kwan, Scarlett Lin Gomez, Alfred I. Neugut - Breast Cancer Research and Treatment 2010 被引用: 880

  11. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    著者: Dawn L. Hershman, Christina Lacchetti, Robert H. Dworkin, Elizabeth Smith, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Patrick G. Gavin, Antoinette Lavino, Maryam B. Lustberg, Judith A. Paice, Bryan P. Schneider, Mary Lou Smith, Tom Smith, Shelby A. Terstriep, Nina D. Wagner‐Johnston, Kate Bak, Charles L. Loprinzi - Journal of Clinical Oncology 2014 被引用: 1,220

  12. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study

    著者: Heather Greenlee, Carlos Iribarren, Jamal S. Rana, Richard K. Cheng, Mai N. Nguyen‐Huynh, Eileen Rillamas‐Sun, Zaixing Shi, Cecile A. Laurent, Valerie S. Lee, Janise M. Roh, Margarita Santiago‐Torres, Hanjie Shen, Dawn L. Hershman, Lawrence H. Kushi, Romain Neugebauer, Marilyn L. Kwan - Journal of Clinical Oncology 2022 被引用: 158

  13. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

    著者: Christine B. Ambrosone, Gary Zirpoli, Alan D. Hutson, William McCann, Susan E. McCann, William E. Barlow, Kara M. Kelly, Rikki Cannioto, Lara E. Sucheston‐Campbell, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobágyi, Julie R. Gralow, G. Thomas Budd, Kathy S. Albain - Journal of Clinical Oncology 2019 被引用: 234

  14. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival

    著者: Rikki Cannioto, Alan D. Hutson, Shruti Dighe, William McCann, Susan E. McCann, Gary Zirpoli, William E. Barlow, Kara M. Kelly, Carol A DeNysschen, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobágyi, Julie R. Gralow, Kathy S. Albain, G. Thomas Budd, Christine B. Ambrosone - JNCI Journal of the National Cancer Institute 2020 被引用: 187

  15. National Estimates of Gender-Affirming Surgery in the US

    著者: Jason D. Wright, Ling Chen, Yukio Suzuki, Koji Matsuo, Dawn L. Hershman - JAMA Network Open 2023 被引用: 166

  16. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study

    著者: Tara Sanft, Maura Harrigan, Courtney McGowan, Brenda Cartmel, Michelle Zupa, Fangyong Li, Leah M. Ferrucci, Leah Puklin, Anlan Cao, Thai Hien Nguyen, Marian L. Neuhouser, Dawn L. Hershman, Karen Basen‐Engquist, Beth A. Jones, Tish Knobf, Anees B. Chagpar, Andrea Silber, Anna Tanasijevic, Jennifer A. Ligibel, Melinda L. Irwin - Journal of Clinical Oncology 2023 被引用: 86

  17. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer

    著者: Dawn L. Hershman, Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke, Alice Tam Kengla, Marianne K. Melnik, Carla Walker Jorgensen, William Kreisle, Lori M. Minasian, Michael Fisch, N. Lynn Henry, Katherine D. Crew - JAMA 2018 被引用: 287

  18. Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

    著者: Tizita Zeleke, Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J. Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S. Trivedi, Melissa Accordino, Katherine D. Crew, Dawn L. Hershman, Matthew Maurer, Simon Jones, Anthony A. High, Junmin Peng, Andrea Califano, Kevin Kalinsky, Jiyang Yu, Jose Silva - Nature Cancer 2022 被引用: 77

  19. Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

    著者: Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei‐Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I. Neugut - Journal of Clinical Oncology 2010 被引用: 829

  20. Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors

    著者: Melinda L. Irwin, Brenda Cartmel, Cary P. Gross, Elizabeth Ercolano, Fangyong Li, Xiaopan Yao, Martha Fiellin, Scott Capozza, Marianna Rothbard, Zhou Yang, Maura Harrigan, Tara Sanft, Kathryn H. Schmitz, Tuhina Neogi, Dawn L. Hershman, Jennifer A. Ligibel - Journal of Clinical Oncology 2014 被引用: 322

  21. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines

    著者: Jason D. Wright, Koji Matsuo, Yongmei Huang, Ana I. Tergas, June Y. Hou, Fady Khoury‐Collado, Caryn M. St. Clair, Cande V. Ananth, Alfred I. Neugut, Dawn L. Hershman - Obstetrics and Gynecology 2019 被引用: 294

  22. Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials

    著者: Joseph M. Unger, Anna Moseley, Banu Symington, Mariana Chávez‐MacGregor, Scott D. Ramsey, Dawn L. Hershman - JAMA Network Open 2018 被引用: 206

  23. Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials

    著者: Joseph M. Unger, Anna Moseley, Christabel K. Cheung, Raymond U. Osarogiagbon, Banu Symington, Scott D. Ramsey, Dawn L. Hershman - Journal of Clinical Oncology 2021 被引用: 145

  24. American Society of Clinical Oncology Position Statement on Obesity and Cancer

    著者: Jennifer A. Ligibel, Catherine M. Alfano, Kerry S. Courneya, Wendy Demark‐Wahnefried, Robert A. Burger, Rowan T. Chlebowski, Carol J. Fabian, Ayca Gucalp, Dawn L. Hershman, Melissa M. Hudson, Lee W. Jones, Madhuri Kakarala, Kirsten K. Ness, Janette K. Merrill, Dana S. Wollins, Clifford A. Hudis - Journal of Clinical Oncology 2014 被引用: 524